Skip to main content
menu
2024 KL2 Career Development Awards Announced for Early Career Clinical and Translational Scientists

2024 KL2 Career Development Awards Announced for Early Career Clinical and Translational Scientists

The next generation of clinical and translational scientists at URMC are receiving two years of support through the UR CTSI Career Development Award (KL2). The KL2 creates opportunity for up-and-coming researchers to design a pilot project that will lead to a K- or R-award application under the guidance of a mentorship team of experienced researchers. Four researchers are receiving a KL2 award for 2024.

Building Better Tools to Predict Kidney Injury in Kids

Building Better Tools to Predict Kidney Injury in Kids

Expanding on work supported by the UR CTSI KL2 Career Development Program, Adam Dziorny, MD, PhD, is building a tool using artificial intelligence to predict acute kidney injury risk in children and alert health care providers.

UR CTSI Seeking Associate Director for KL2 Career Development Program

UR CTSI Seeking Associate Director for KL2 Career Development Program

The UR CTSI KL2 Career Development program has launched the careers of dozens of clinical and translational scientists since it was established in 2006. Interested candidates should submit a CV by February 12, 2024.

Students Tackle FDA Focus Areas in America’s Got Regulatory Science Talent Competition

Students Tackle FDA Focus Areas in America’s Got Regulatory Science Talent Competition

The annual competition challenges students to develop regulatory science proposals, the best of which will be presented to the FDA in the spring.

Capellan Selected for GEPA Postdoctoral Appointee Award for Excellence in Equity and Inclusion

Capellan Selected for GEPA Postdoctoral Appointee Award for Excellence in Equity and Inclusion

Jahaira Capellan, PhD, MS, RN, FNP-BC is this year’s recipient of the GEPA Postdoctoral Appointee Award for Excellence in Equity and Inclusion.